Menu
1-702-720-6310 info@microcapspecualtors.com

Biotech Premarket Movers: Aurinia, Puma, PTC, Juno – TheStreet.com


TheStreet.com

Biotech Premarket Movers: Aurinia, Puma, PTC, Juno
TheStreet.com
Puma Biotechnology (PBYI) shares fell 25.1% to $28.50 after Swiss drugmaker Roche AG announced positive results from a phase three study involving Roche’s breast cancer drug Perjeta. Perjeta’s success spells trouble for Los Angeles-based Puma, which …
Puma Biotech shares plummet 26% after Roche reports positive results for late-stage breast cancer drugMarketWatch
Thursday’s Biotech Insights: Aurinia Pharmaceuticals Inc (AUPH), Puma Biotechnology Inc (PBYI)Smarter Analyst
Puma Biotech Falls 20%, But Starts To RecoverBenzinga

all 34 news articles »

Search